Skip to main content

Advertisement

Log in

c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Xeroderma pigmentosum is a rare autosomal recessive disease characterized by hypersensitivity to UV light which is due to alterations of the nucleotide excision repair pathway. Eight genes (XPA to XPG and XPV) are responsible for the disease. Among them, the XPC gene is known to be the most mutated in Mediterranean patients. The aim of this study was to determine the frequency of the most common XPC mutation and describe the clinical features of Moroccan patients with xeroderma pigmentosum. Twenty four patients belonging to 21 unrelated Moroccan families and 58 healthy subjects were investigated. After clinical examination, the screening for the c.1643_1644delTG (p.Val548AlafsX25) mutation in the XPC gene was performed by PCR and automated sequencing of exon 9 in all patients and controls. The molecular analysis showed that among the 24 patients, 17 were homozygous for the c.1643_1644delTG mutation and all their tested parents were heterozygous, whereas the others (7 patients) did not carry the mutation. The frequency of this mutation was estimated to be 76.19 % (16/21 families). None of the 58 healthy individuals carried this mutation. In addition, clinical investigation showed that the majority of the patients bearing this mutation have the same clinical features. Our results revealed that the p.Val548AlafsX25 mutation is the major cause (76.19 %) of xeroderma pigmentosum in Moroccan families. This would have an important impact on improving management of patients and their relatives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Araki M, Masutani C, Takemura M, Uchida A, Sugasawa K et al (2001) Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J Biol Chem 276:18665–18672

    Article  PubMed  CAS  Google Scholar 

  2. Ben Rekaya M, Messaoud O, Talmoudi F, Nouira S, Ouragini H et al (2009) High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis. J Hum Genet 54:426–429

    Article  PubMed  CAS  Google Scholar 

  3. Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ (1998) Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: Vogelstein B, Kinzler KW (eds) The genetic basis of human cancer. McGraw-Hill, New York, pp 245–274

    Google Scholar 

  4. Bootsma D, Kraemer KH, Cleaver JJ (2001) Hoeijmakers nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. In: Sly W, Valle D, Scriver AB (eds) The metabolic basis of inherited disease. McGraw-Hill Book Co, New York, pp 245–274

    Google Scholar 

  5. Bunick CG, Miller MR, Fuller BE, Fanning E, Chazin WJ (2006) Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein. Biochemistry 45:14965–14979

    Article  PubMed  CAS  Google Scholar 

  6. Chavanne F, Broughton BC, Pietra D, Nardo T, Browitt A et al (2000) Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res 60:1974–1982

    PubMed  CAS  Google Scholar 

  7. Daya-Grosjean L, James MR, Drougard C, Sarasin A (1987) An immortalized xeroderma pigmentosum, group C, cell line which replicates SV40 shuttle vectors. Mutat Res 183:185–196

    Article  PubMed  CAS  Google Scholar 

  8. Fazaa B, Zghal M, Bailly C, Zeglaoui F, Goucha S et al (2001) Melanoma in xeroderma pigmentosum: 12 cases. Ann Dermatol Venereol 128:503–506

    PubMed  CAS  Google Scholar 

  9. Hanawalt PC (2002) Subpathways of nucleotide excision repair and their regulation. Oncogene 21:8949–8956

    Article  PubMed  CAS  Google Scholar 

  10. Hirai Y, Kodama Y, Moriwaki S, Noda A, Cullings HM et al (2006) Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1 % of the Japanese population. Mutat Res 601:171–178

    Article  PubMed  CAS  Google Scholar 

  11. Khan SG, Oh KS, Shahlavi T, Ueda T, Busch DB et al (2006) Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 27:84–94

    Article  PubMed  CAS  Google Scholar 

  12. Khatri ML, Bemghazil M, Shafi M, Machina A (1999) Xeroderma pigmentosum in Libya. Int J Dermatol 38:520–524

    Article  PubMed  CAS  Google Scholar 

  13. Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241–250

    Article  PubMed  CAS  Google Scholar 

  14. Lehmann AR (2003) DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85:1101–1111

    Article  PubMed  CAS  Google Scholar 

  15. Li L, Bales ES, Peterson CA, Legerski RJ (1993) Characterization of molecular defects in xeroderma pigmentosum group C. Nat Genet 5:413–417

    Article  PubMed  CAS  Google Scholar 

  16. Maillard O, Solyom S, Naegeli H (2007) An aromatic sensor with aversion to damaged strands confers versatility to DNA repair. PLoS Biol 5:e79

    Article  PubMed  Google Scholar 

  17. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  18. Moriwaki S, Kraemer KH (2001) Xeroderma pigmentosum—bridging a gap between clinic and laboratory. Photodermatol Photoimmunol Photomed 17:47–54

    Article  PubMed  CAS  Google Scholar 

  19. Moussaid L, Benchikhi H, Boukind EH, Sqalli S, Mouaki N et al (2004) Cutaneous tumors during xeroderma pigmentosum in Morocco: study of 120 patients. Ann Dermatol Venereol 131:29–33

    Article  PubMed  CAS  Google Scholar 

  20. Rezvani HR, Ged C, Bouadjar B, de Verneuil H, Taieb A (2008) Catalase overexpression reduces UVB-induced apoptosis in a human xeroderma pigmentosum reconstructed epidermis. Cancer Gene Ther 15:241–251

    Article  PubMed  CAS  Google Scholar 

  21. Rivera-Begeman A, McDaniel LD, Schultz RA, Friedberg EC (2007) A novel XPC pathogenic variant detected in archival material from a patient diagnosed with xeroderma pigmentosum: a case report and review of the genetic variants reported in XPC. DNA Repair (Amst) 6:100–114

    Article  CAS  Google Scholar 

  22. Sarasin A, Stary A (2007) New insights for understanding the transcription-coupled repair pathway. DNA Repair (Amst) 6:265–269

    Article  CAS  Google Scholar 

  23. Soufir N, Ged C, Bourillon A, Austerlitz F, Chemin C et al (2010) A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. J Invest Dermatol 130:1537–1542

    Article  PubMed  CAS  Google Scholar 

  24. Stary A, Sarasin A (2002) The genetics of the hereditary xeroderma pigmentosum syndrome. Biochimie 84:49–60

    Article  PubMed  CAS  Google Scholar 

  25. Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ et al (1998) xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 2:223–232

    Article  PubMed  CAS  Google Scholar 

  26. Thoms K-M, Kuschal C, Emmert S (2007) Lessons learned from DNA repair defective syndromes. Exp Dermatol 16(6):532–544

    Article  PubMed  CAS  Google Scholar 

  27. Van Steeg H, Kraemer KH (1999) xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today 5:86–94

    Article  PubMed  Google Scholar 

  28. Venema J, van Hoffen A, Karcagi V, Natarajan AT, van Zeeland AA et al (1991) xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol Cell Biol 11:4128–4134

    PubMed  CAS  Google Scholar 

  29. Zghal M, El-Fekih N, Fazaa B, Fredj M, Zhioua R et al (2005) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 49 Tunisian cases. Tunis Med 83:760–763

    PubMed  Google Scholar 

Download references

Acknowledgments

We thank all families for their cooperation. We also thank the team of dermatology of Ibn Rochd Hospital (Casablanca, Morocco) for their collaboration and effective participation in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abdelhamid Barakat.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Senhaji, M.A., Abidi, O., Nadifi, S. et al. c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum. Arch Dermatol Res 305, 53–57 (2013). https://doi.org/10.1007/s00403-012-1299-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-012-1299-0

Keywords

Navigation